Add Company
Join Now

PhaseV Revenue and Competitors

License our Company Data API

Boston, MA USA

Location

$15M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • PhaseV's estimated annual revenue is currently $7.2M per year.(i)
  • PhaseV's estimated revenue per employee is $201,000
  • PhaseV's total funding is $15M.

Employee Data

  • PhaseV has 36 Employees.(i)
  • PhaseV grew their employee count by 44% last year.

PhaseV's People

NameTitleEmail/Phone
1
CEO and Co-FounderReveal Email/Phone
2
CEO, Co-FounderReveal Email/Phone
3
CTO & Co-FounderReveal Email/Phone
4
Scientific Co-FounderReveal Email/Phone
5
Head R&DReveal Email/Phone
6
Head Business OperationsReveal Email/Phone
7
Head Business DevelopmentReveal Email/Phone
8
Senior DirectorReveal Email/Phone
9
Medical DirectorReveal Email/Phone
10
Office ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3400%$634MN/A
#2
$57.9M2880%N/AN/A
#3
$2M10-17%N/AN/A
#4
$33.6M16720%N/AN/A
#5
$15.5M77126%N/AN/A
#6
$25.1M1258%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.1M50-2%N/AN/A
#9
$1.8M385-4%$538MN/A
#10
$46.6M232-7%N/AN/A
Add Company

What Is PhaseV?

PhaseV is leveraging cutting-edge algorithms such as reinforcement learning and causal ML for adaptive trial design and closed-loop execution, in order to improve trial success rate while maximizing resource and time efficiency. Our novel methodology and advanced technology also enable the detection of hidden signals in data while analyzing clinical trial results and extracting actionable insights.

keywords:N/A

$15M

Total Funding

36

Number of Employees

$7.2M

Revenue (est)

44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.8M36-18%$2.5M
#2
$9.7M36-27%$55.3M
#3
$7.2M363%N/A
#4
$3.6M363%$94M
#5
$9M363%N/A